investorscraft@gmail.com

Stock Analysis & ValuationANI Pharmaceuticals, Inc. (ANIP)

Previous Close
$70.49
Sector Valuation Confidence Level
High
Valuation methodValue, $Upside, %
Artificial intelligence (AI)96.2937
Intrinsic value (DCF)2258.393104
Graham-Dodd Method42.52-40
Graham Formula195.43177

Company Information

210 Main Street West
Baudette, MN 56623
United States
Phone: 218 634 3500
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
CEO: Nikhil Lalwani
Full Time Employees: 897

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.

HomeMenuAccount